| Unknown | Study of Pulmonary Hypertension in Patients With Chronic Myeloproliferative Disorders at Sohag University Hosp NCT04843475 | Sohag University | — |
| Completed | Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malig NCT02556931 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell NCT00448201 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Completed | INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative NCT01164163 | Children's Oncology Group | Phase 1 |
| Terminated | Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Underg NCT01116232 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Terminated | Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Canc NCT00946283 | Rutgers, The State University of New Jersey | N/A |
| Terminated | Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant NCT01077440 | Vanderbilt University | — |
| Recruiting | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer NCT00935090 | Barbara Ann Karmanos Cancer Institute | — |
| Recruiting | Registry of Older Patients With Cancer NCT01137825 | UNC Lineberger Comprehensive Cancer Center | — |
| Recruiting | Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643 | UNC Lineberger Comprehensive Cancer Center | — |
| Terminated | Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer NCT00726830 | M.D. Anderson Cancer Center | N/A |
| Completed | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer NCT00823524 | Asan Medical Center | Phase 1 / Phase 2 |
| Completed | Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone NCT00993694 | Vanderbilt University | — |
| Terminated | Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunte NCT00952185 | City of Hope Medical Center | N/A |
| Terminated | Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transpla NCT00800150 | City of Hope Medical Center | Phase 1 |
| Completed | American Ginseng in Treating Patients With Fatigue Caused by Cancer NCT00719563 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor NCT00755040 | Vanderbilt-Ingram Cancer Center | Phase 3 |
| Withdrawn | Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Ca NCT00816413 | University of Nebraska | Phase 1 / Phase 2 |
| Terminated | Blood Samples From Patients on a Clinical Trial to CINV During HSCT NCT00900068 | OHSU Knight Cancer Institute | — |
| Terminated | Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transpla NCT00813501 | City of Hope Medical Center | — |
| Completed | A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transp NCT00782145 | Tufts Medical Center | Phase 3 |
| Withdrawn | Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers NCT00770419 | Rutgers, The State University of New Jersey | — |
| Completed | CC-4047 in Treating Patients With Myelofibrosis NCT00669578 | Mayo Clinic | Phase 1 / Phase 2 |
| Completed | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hem NCT00691015 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Completed | Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clin NCT00750009 | Case Comprehensive Cancer Center | Phase 3 |
| Terminated | Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis NCT00630994 | Mayo Clinic | Phase 2 |
| Completed | Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in NCT00516503 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Under NCT00513474 | Massachusetts General Hospital | Phase 1 |
| Terminated | Studying Fentanyl in Patients With Cancer NCT00899951 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoi NCT00589563 | City of Hope Medical Center | Phase 2 |
| Completed | Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Pa NCT00806767 | Institut Paoli-Calmettes | Phase 2 |
| Completed | Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients Wit NCT00438958 | The Canadian Blood and Marrow Transplant Group | Phase 3 |
| Completed | Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders NCT00433862 | National Institutes of Health Clinical Center (CC) | — |
| Completed | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases NCT00453206 | Wake Forest University Health Sciences | N/A |
| Completed | Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Ce NCT00964821 | City of Hope Medical Center | — |
| Completed | Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant NCT00900406 | Vanderbilt-Ingram Cancer Center | — |
| Completed | Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases NCT00424242 | Northwestern University | EARLY_Phase 1 |
| Terminated | T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant NCT00651716 | Vanderbilt-Ingram Cancer Center | — |
| Terminated | Azacitidine in Treating Patients With Myelofibrosis NCT00381693 | Mayo Clinic | Phase 2 |
| Completed | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Ha NCT00410657 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or NCT00376922 | Wake Forest University Health Sciences | N/A |
| Terminated | Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant NCT00324324 | OHSU Knight Cancer Institute | Phase 3 |
| Completed | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis NCT00132015 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacroli NCT00346359 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer NCT00281879 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant NCT00281814 | The Cleveland Clinic | — |
| Completed | Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation NCT00281801 | Case Comprehensive Cancer Center | — |
| Completed | Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myel NCT00293410 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen NCT00448357 | UNC Lineberger Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Completed | Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder NCT00274820 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders NCT00437086 | Mayo Clinic | EARLY_Phase 1 |
| Completed | A Standardized Nursing Intervention Protocol for HCT Patients NCT00951626 | City of Hope Medical Center | N/A |
| Terminated | Imatinib Mesylate in Treating Patients With Myelofibrosis NCT00245128 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Tr NCT00245037 | OHSU Knight Cancer Institute | Phase 1 / Phase 2 |
| Completed | Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, NCT00114257 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain NCT00666211 | Vanderbilt-Ingram Cancer Center | Phase 3 |
| Unknown | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic NCT00295997 | University of California, San Francisco | N/A |
| Completed | Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer NCT00104923 | California Cancer Consortium | Phase 1 |
| Completed | Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing NCT00104975 | Yale University | Phase 1 |
| Completed | Campath-1H + FK506 and Methylprednisolone for GVHD NCT00109993 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Be NCT00293384 | Barbara Ann Karmanos Cancer Institute | N/A |
| Completed | Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone NCT00134004 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia NCT00445900 | Mayo Clinic | Phase 2 |
| Completed | Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced H NCT00096096 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer NCT00134017 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Terminated | G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders NCT00253552 | OHSU Knight Cancer Institute | N/A |
| Withdrawn | Collecting and Storing Blood Samples From Patients With Cancer NCT00900120 | University of Medicine and Dentistry of New Jersey | — |
| Completed | T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-I NCT00080925 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Terminated | T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients W NCT00589602 | The Cleveland Clinic | Phase 2 |
| Terminated | Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil i NCT00255684 | University of Rochester | N/A |
| Completed | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematol NCT00089037 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation NCT00064311 | National Institutes of Health Clinical Center (CC) | Phase 1 / Phase 2 |
| Completed | Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Mal NCT00068523 | Case Comprehensive Cancer Center | N/A |
| Completed | Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoi NCT00054340 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoi NCT00255710 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantat NCT00053157 | Roswell Park Cancer Institute | N/A |
| Completed | Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologi NCT00054236 | Case Comprehensive Cancer Center | Phase 1 |
| Terminated | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer NCT00062231 | European Organisation for Research and Treatment of Cancer - EORTC | N/A |
| Completed | Pyroxamide in Treating Patients With Advanced Cancer NCT00042900 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients NCT00082654 | Fred Hutchinson Cancer Center | N/A |
| Completed | Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer NCT00036790 | University of Wisconsin, Madison | Phase 1 |
| Completed | NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders NCT00053989 | Roswell Park Cancer Institute | Phase 2 |
| Unknown | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiat NCT00036712 | Medical College of Wisconsin | Phase 2 |
| Withdrawn | Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer NCT00301912 | University of California, San Francisco | Phase 2 |
| Completed | Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukem NCT00049634 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Terminated | Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients Wit NCT00069992 | Baylor College of Medicine | Phase 2 |
| Active Not Recruiting | Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders NCT00544115 | City of Hope Medical Center | Phase 2 |
| Completed | Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and M NCT00290641 | Masonic Cancer Center, University of Minnesota | N/A |
| Completed | Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High- NCT00014482 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Tre NCT00006348 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Tipifarnib in Treating Patients With Advanced Hematologic Cancer NCT00005967 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, NCT00010283 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA NCT00006379 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis NCT00006367 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter NCT00006083 | Jonsson Comprehensive Cancer Center | Phase 3 |
| Completed | Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone M NCT00716911 | City of Hope Medical Center | N/A |
| Completed | St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer NCT00005805 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Terminated | 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment NCT00004239 | Alliance for Clinical Trials in Oncology | Phase 1 |
| Completed | EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer NCT00004258 | Indiana University School of Medicine | Phase 1 |
| Completed | Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00004232 | Northwestern University | Phase 1 |
| Terminated | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer NCT00290628 | Masonic Cancer Center, University of Minnesota | N/A |
| Completed | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00005804 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leuk NCT00004181 | Northwestern University | Phase 2 |
| Completed | Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00004904 | Northwestern University | Phase 1 |
| Completed | Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer NCT00296023 | University of California, San Francisco | N/A |
| Completed | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy NCT00003600 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder NCT00004058 | University of Medicine and Dentistry of New Jersey | Phase 1 |
| Completed | Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematolog NCT00003816 | Roswell Park Cancer Institute | Phase 2 / Phase 3 |
| Completed | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transp NCT00003887 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer NCT00003451 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Treatment for Chronic Pain in Patients With Advanced Cancer NCT00003687 | NCIC Clinical Trials Group | Phase 3 |
| Completed | Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With C NCT00003408 | Cancer Treatment Centers of America | Phase 2 |
| Completed | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients NCT00003619 | Drexel University College of Medicine | Phase 1 / Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Advanced Cancer NCT00003331 | NYU Langone Health | Phase 1 |
| Completed | Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer NCT00003082 | University of Arizona | Phase 1 |
| Unknown | Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer NCT00004036 | The Cleveland Clinic | Phase 1 |
| Completed | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory NCT00003406 | Cancer Treatment Centers of America | Phase 1 / Phase 2 |
| Completed | Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors NCT00003107 | Indiana University School of Medicine | Phase 1 |
| Terminated | Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation NCT00005641 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | Decitabine in Treating Patients With Melanoma or Other Advanced Cancer NCT00002980 | California Cancer Consortium | Phase 1 |
| Completed | Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With My NCT00002792 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Mar NCT00005852 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorde NCT00005622 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer NCT00002742 | Aronex Pharmaceuticals | Phase 3 |
| Completed | Bone Marrow Transplant in Treating Patients With Hematologic Cancers NCT00005797 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer NCT00002504 | Hoag Memorial Hospital Presbyterian | Phase 2 |
| Completed | Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma NCT00900055 | OHSU Knight Cancer Institute | — |
| Terminated | Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia NCT00066417 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Withdrawn | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Bloo NCT01101412 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |